Thomas E. Starzl Transplantation Institute, Departments of Surgery, Immunology, and Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Immunobiology and Transplant Science Center, Houston Methodist Hospital, Texas Medical Center, Houston, TX, USA.
Am J Transplant. 2018 Feb;18(2):289-292. doi: 10.1111/ajt.14436. Epub 2017 Aug 24.
Innate recognition of microbial products and danger molecules by monocytes and macrophages has been well established; this is mediated primarily by pattern-recognition receptors and is central to the activation of innate and adaptive immune cells required for productive immunity. Whether monocytes and macrophages are equipped with an allorecognition system that allows them to respond directly to allogeneic grafts is a topic of much debate. Recent studies provide compelling evidence that these cells can recognize allogeneic entities and that they mediate graft rejection via direct cytotoxicity and priming of alloreactive T cells. In addition, these studies have uncovered a mechanism of innate allorecognition based on detection of the polymorphic molecule signal regulatory protein α (SIRPα) on donor cells. Further understanding of innate allorecognition and its consequences would provide essential insight into allograft rejection and lead to better therapies for transplant patients.
先天识别微生物产物和危险分子的单核细胞和巨噬细胞已经得到很好的确立; 这主要是通过模式识别受体介导的,是激活先天和适应性免疫细胞所必需的,以产生有效的免疫。单核细胞和巨噬细胞是否配备了允许它们直接对同种异体移植物作出反应的同种异体识别系统,这是一个争论的话题。最近的研究提供了令人信服的证据表明,这些细胞可以识别同种异体实体,并通过直接细胞毒性和同种反应性 T 细胞的激活来介导移植物排斥。此外,这些研究还揭示了一种基于对供体细胞上多态分子信号调节蛋白 α (SIRPα)的检测的先天同种异体识别机制。进一步了解先天同种异体识别及其后果将为同种异体移植排斥提供重要的见解,并为移植患者提供更好的治疗方法。